Skip to main content

Find Clinical Trials

Home
Conditions
Huntington Disease

Clinical trial condition

Huntington Disease

Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.

141 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Huntington Disease trial results

Completed

Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride

NCT00632645

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: CHU Henri Mondor Créteil, France

View Trial Details

Completed

MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease

NCT00190450

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Hopital Henri Mondor Paris, Île-de-France Region, France

View Trial Details

Completed

REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)

NCT01590589

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Universitätsklinik für Psychiatrie, Neuropsychiatrische Ambulanz Graz, Austria

Universitätsklinik Innsbruck, Neurologie Innsbruck, Austria

UCL-St Luc, Centre de génétique humaine Brussels, Belgium

Institute of Pathology and Genetics (IPG) Gosselies, Belgium

View all 140 locations

View Trial Details

Completed

Making Sense of a Positive Genetic Test Result for Huntington Disease

NCT00539747

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease

NCT01602900

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: GSK Investigational Site London, United Kingdom

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

NCT01573819

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: GSK Investigational Site Zuidlaren, Netherlands

View Trial Details

Completed

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

NCT00970229

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

View Trial Details

Completed

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

NCT00870974

Conditions: Alzheimer Disease, Autism Spectrum Disorder, Autistic Spectrum Disorders, +33 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

View Trial Details

Completed

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm

NCT02814201

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: CHU Amiens Amiens, France

View Trial Details

Completed

A Pre-Cellular Therapy Observational Study in Early Huntington's Disease

NCT01937923

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: UC Davis Medical Center, Clinical Research Center Sacramento, California, United States

View Trial Details